These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
769 related items for PubMed ID: 15712176
1. T-bet, a T cell-associated transcription factor, is expressed in Hodgkin's lymphoma. Dorfman DM, Hwang ES, Shahsafaei A, Glimcher LH. Hum Pathol; 2005 Jan; 36(1):10-5. PubMed ID: 15712176 [Abstract] [Full Text] [Related]
2. T-bet, a T-cell-associated transcription factor, is expressed in a subset of B-cell lymphoproliferative disorders. Dorfman DM, Hwang ES, Shahsafaei A, Glimcher LH. Am J Clin Pathol; 2004 Aug; 122(2):292-7. PubMed ID: 15323146 [Abstract] [Full Text] [Related]
3. Histiocyte-rich B-cell lymphoma. A distinct clinicopathologic entity possibly related to lymphocyte predominant Hodgkin's disease, paragranuloma subtype. Delabie J, Vandenberghe E, Kennes C, Verhoef G, Foschini MP, Stul M, Cassiman JJ, De Wolf-Peeters C. Am J Surg Pathol; 1992 Jan; 16(1):37-48. PubMed ID: 1728195 [Abstract] [Full Text] [Related]
4. Neuron-specific enolase (gamma enolase, gamma-gamma dimer) expression in Hodgkin's disease and large cell lymphomas. Massarelli G, Onida GA, Piras MA, Marras V, Mura A, Tanda F. Anticancer Res; 1999 Jan; 19(5B):3933-8. PubMed ID: 10628334 [Abstract] [Full Text] [Related]
5. Fascin, a sensitive new marker for Reed-Sternberg cells of hodgkin's disease. Evidence for a dendritic or B cell derivation? Pinkus GS, Pinkus JL, Langhoff E, Matsumura F, Yamashiro S, Mosialos G, Said JW. Am J Pathol; 1997 Feb; 150(2):543-62. PubMed ID: 9033270 [Abstract] [Full Text] [Related]
6. Correlation of high numbers of intratumoral FOXP3+ regulatory T cells with improved survival in germinal center-like diffuse large B-cell lymphoma, follicular lymphoma and classical Hodgkin's lymphoma. Tzankov A, Meier C, Hirschmann P, Went P, Pileri SA, Dirnhofer S. Haematologica; 2008 Feb; 93(2):193-200. PubMed ID: 18223287 [Abstract] [Full Text] [Related]
7. CD40 ligand is constitutively expressed in a subset of T cell lymphomas and on the microenvironmental reactive T cells of follicular lymphomas and Hodgkin's disease. Carbone A, Gloghini A, Gruss HJ, Pinto A. Am J Pathol; 1995 Oct; 147(4):912-22. PubMed ID: 7573367 [Abstract] [Full Text] [Related]
8. Clusterin expression in malignant lymphomas: a survey of 266 cases. Saffer H, Wahed A, Rassidakis GZ, Medeiros LJ. Mod Pathol; 2002 Nov; 15(11):1221-6. PubMed ID: 12429802 [Abstract] [Full Text] [Related]
9. CD30 distribution. Immunohistochemical study on formaldehyde-fixed, paraffin-embedded Hodgkin's and non-Hodgkin's lymphomas. Miettinen M. Arch Pathol Lab Med; 1992 Nov; 116(11):1197-201. PubMed ID: 1332642 [Abstract] [Full Text] [Related]
10. Expression of CD95 antigen and Bcl-2 protein in non-Hodgkin's lymphomas and Hodgkin's disease. Nguyen PL, Harris NL, Ritz J, Robertson MJ. Am J Pathol; 1996 Mar; 148(3):847-53. PubMed ID: 8774139 [Abstract] [Full Text] [Related]
11. Differential expression of T-bet, a T-box transcription factor required for Th1 T-cell development, in peripheral T-cell lymphomas. Dorfman DM, van den Elzen P, Weng AP, Shahsafaei A, Glimcher LH. Am J Clin Pathol; 2003 Dec; 120(6):866-73. PubMed ID: 14671975 [Abstract] [Full Text] [Related]
12. Dendritic reticulum cell immunoreactivity for low-affinity nerve growth factor receptor in malignant lymphomas. Dorfman DM, Shahsafaei A. Mod Pathol; 1996 Oct; 9(10):959-65. PubMed ID: 8902831 [Abstract] [Full Text] [Related]
13. How to differentiate between T-cell-rich B-cell lymphoma and lymphocyte-predominant Hodgkin's disease. Evidence for the value of MB1 and 4KB5 immunostaining. Schmidt U, Herbst J, Metz KA, Leder LD. J Pathol; 1996 Jun; 179(2):138-44. PubMed ID: 8758204 [Abstract] [Full Text] [Related]
14. The early transcription factor GATA-2 is expressed in classical Hodgkin's lymphoma. Schneider EM, Torlakovic E, Stühler A, Diehl V, Tesch H, Giebel B. J Pathol; 2004 Dec; 204(5):538-45. PubMed ID: 15538755 [Abstract] [Full Text] [Related]
15. Peripheral T-cell non-Hodgkin's lymphoma following treatment of nodular lymphocyte predominance Hodgkin's disease. Rysenga E, Linden MD, Carey JL, Ross CW, Schnitzer B, Sawdyk M, Maeda K. Arch Pathol Lab Med; 1995 Jan; 119(1):88-91. PubMed ID: 7802562 [Abstract] [Full Text] [Related]
16. Hodgkin's disease, lymphocyte predominance type, nodular--further evidence for a B cell derivation. L & H variants of Reed-Sternberg cells express L26, a pan B cell marker. Pinkus GS, Said JW. Am J Pathol; 1988 Nov; 133(2):211-7. PubMed ID: 3263805 [Abstract] [Full Text] [Related]
18. Cytotoxic protein expression in non-Hodgkin's lymphomas and Hodgkin's disease. Kanavaros P, Vlychou M, Stefanaki K, Rontogianni D, Gaulard P, Pantelidaki E, Zois M, Darivianaki K, Georgoulias V, Boulland ML, Gorgoulis V, Kittas C. Anticancer Res; 1999 Oct; 19(2A):1209-16. PubMed ID: 10368677 [Abstract] [Full Text] [Related]
19. Preferential expression of the mucosal homing receptor integrin alpha 4 beta 7 in gastrointestinal non-Hodgkin's lymphomas. Drillenburg P, van der Voort R, Koopman G, Dragosics B, van Krieken JH, Kluin P, Meenan J, Lazarovits AI, Radaszkiewicz T, Pals ST. Am J Pathol; 1997 Mar; 150(3):919-27. PubMed ID: 9060830 [Abstract] [Full Text] [Related]
20. High expression of the CC chemokine TARC in Reed-Sternberg cells. A possible explanation for the characteristic T-cell infiltratein Hodgkin's lymphoma. van den Berg A, Visser L, Poppema S. Am J Pathol; 1999 Jun; 154(6):1685-91. PubMed ID: 10362793 [Abstract] [Full Text] [Related] Page: [Next] [New Search]